[Lymphoplasmacytoid lymphoma and the immune system in patients with this type of lymphoma].
Among 82 patients with L-LP in clinical stage IV, 14% were found to have monoclonal gammapathy and 22% polyclonal gammapathy. The other classes of immunoglobulins were not affected. In 78%, cell immunity was impaired. Decrease in T cell count (CD2+ and CD3+) in blood was found. Particularly T helper cells (CD4+), to a lesser degree T suppressor cells (CD8+) were affected. The life time of patients varied from 3 to 120 months. 60% of deaths were caused by infection.
Dwilewicz-Trojaczek
J
J
Kliniki Hematologii AM w Warszawie.
Kendziorek
A
A
Paprocka
E
E
Wieczorek
J
J
Widzyńska
I
I
Kuratowska
Z
Z
D015703:Antigens, CD / Q000032:analysis; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology* / Q000401:mortality / Q000473:pathology; D018655:Lymphocyte Count; D009367:Neoplasm Staging; D015996:Survival Rate
D015703:Antigens, CD; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M